Live Breaking News & Updates on Glenmark life

Stay informed with the latest breaking news from Glenmark life on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Glenmark life and stay connected to the pulse of your community

glenmark q3 earnings update: Glenmark Q3 Results: Co reports net loss of Rs 351 cr on lower domestic sales

Total revenue from operations declined to Rs 2,507 crore as compared with Rs 3,100 crore in the year-ago period, Glenmark Pharma said in a statement.

India , New-delhi , Delhi , United-states , Mumbai , Maharashtra , America , Glenn-saldanha , Glenmark-pharma , Glenmark-pharmaceuticals-on , Glenmark-life-sciences , Glenmark-pharmaceuticals

Nirma Rs 1,343 crore open offer to buy more stake in Glenmark Life Sciences to start on Feb 15

Nirma Rs 1,343 crore open offer to buy more stake in Glenmark Life Sciences to start on Feb 15
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Mumbai , Maharashtra , India , Glenmark-pharmaceuticals , Glenmark-life-sciences-ltd , Nirma-ltd , Glenmark-life-sciences-for-rs , Glenmark-life-sciences , Glenmark-life ,

Latest News | Nirma Rs 1,343 Cr Open Offer to Buy More Stake in Glenmark Life Sciences to Start on Feb 15

Get latest articles and stories on Latest News at LatestLY. Nirma Ltd will kick off a Rs 1,343.05-crore open offer next week to acquire an additional 17.33 per cent stake from public shareholders of Glenmark Life Sciences Ltd, according to a regulatory filing.
Latest News | Nirma Rs 1,343 Cr Open Offer to Buy More Stake in Glenmark Life Sciences to Start on Feb 15.

Mumbai , Maharashtra , India , New-delhi , Delhi , Atal-setu , Glenmark-life-sciences-for-rs , Glenmark-life-sciences-ltd , Nirma-ltd , Glenmark-life-sciences , Glenmark-pharmaceuticals , Bus-service

Taking Stock: Market rebounds; Sensex up 450 points, Nifty above 21,900

Top Nifty gainers included BPCL, HDFC Life and HCLTech, while losers were Power Grid, IndusInd Bank and Britannia Industries

China , Hong-kong , India , Bharat , Maruti-suzuki , Ashoka-buildcon , Bajaj-finserv , Anand-rathi , Britannia-industries , Indusind-bank , Akzo-nobel , Bandhan-bank

Indices shrug-off early losses; Sensex surges 455 points, Nifty tops 21,900

In the broader markets, the BSE MidCap and SmallCap indices advanced 1 per cent and 1.23 per cent , respectively.

China , Hong-kong , India , Bharat , Anand-rathi , Bajaj-finserv , Maruti-suzuki , Ashoka-buildcon , Infosys , Capital-small-finance-bank , Chalet-hotels , Jana-small-finance-bank

bank stocks: Lending businesses are on the table, but as portfolio managers staying out of banking space now: Kenneth Andrade

Kenneth Andrade believes that metal converters and Indian companies in the steel industry are a good bet. The balance sheets of these businesses have improved, with increased cash generation and capacity expansion. The key factor for success is the rise in steel prices, which would lead to a recovery in profitability. Additionally, Andrade mentions the growth potential in the premium liquor segment due to per capita rise in income and the trend of premiumization.

Kozhikode , Kerala , India , Lucknow , Uttar-pradesh , Marksans-pharma , Kenneth-andrade , Prime-minister , Indian-school-of-business , Offering-college , Tata-steel , Old-bridge-capital-management

Glenmark launches biosimilar of anti-diabetic drug, vows to cut down therapy cost by 70%

Priced at around Rs 100 for a standard dose of 1.2 mg (per day), this will lower the cost of therapy by approximately 70 percent

India , United-states , American , Alok-malik , Glenmark-life-sciences , American-diabetes-association , Glenmark-pharmaceuticals-ltd , Glenmark-pharmaceuticals , Drug-controller-general , Glenmark-life , Glenmark , Iraglutide

Short Call | Consolidation or correction, Embassy REIT, Glenmark Pharma, Ashok Leyland in focus

Oil prices have seen an uptick since the Red Sea crisis, and a new variant of COVID-19 has reared its ugly head. Consolidation or corrections remains to be seen.

Red-sea , Djibouti-general- , Djibouti , India , Glenmark-pharma , Ashok-leyland , Futures-open-interest , Glenmark-life , Fo-corner , Mbassy-reit , Lenmark-pharma , Shok-leyland

CCI appoints Ansuman Pattnaik as Director General (Investigation)

CCI appoints Ansuman Pattnaik as Director General (Investigation)
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Delhi , India , Himachal-pradesh , Ansuman-pattnaik , Ravneet-kaur , Income-tax-dispute-resolution-panel-at-delhi , Facebook , Competition-commission-of-india , Twitter , Indian-revenue-service , Linkedin , Google

Stocks in news: Embassy REIT, Nippon AMC, BPCL, Apollo Tyres

Global private equity firm Blackstone Group plans to sell its entire stake in Embassy Office Parks REIT through a mega block deal on Wednesday, according to news reports

Japan , India , Nippon , Mohit-joshi , Blackstone-group , Embassy-office-parks , Glenmark-life-sciences , Indusind-bank , Competition-commission-of-india , Managing-director , Ind-bank , Competition-commission